Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate

被引:32
|
作者
Goh, B. K. P.
Chow, P. K. H.
Chuah, K. L.
Yap, W. M.
Wong, W. K.
机构
[1] Singapore Gen Hosp, Dept Surg, Singapore 169608, Singapore
[2] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore
来源
EJSO | 2006年 / 32卷 / 09期
关键词
gastrointestinal stromal tumor; GIST; neoadjuvant; imatinib; Gleevec; response;
D O I
10.1016/j.ejso.2006.06.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The aim of this study is to review the radiologic, PET scan and pathologic response and the outcome of patients with advanced GIST treated with neoadjuvant IM followed by surgical resection. Materials and methods: We report a case and review 36 patients reported in MEDLINE with advanced GIST treated with neoadjuvant IM followed by surgical resection. Results: Thirty-seven patients with a median age of 56 years (range, 32-76 years) at presentation were treated with neoadjuvant IM. Radiologic response accurately predicted pathological response in 31/36 patients, whereas PET scan was accurate in predicting treatment response in only 6/23 patients. Conclusion: This study demonstrates that the pathologic response of GIST to IM is usually incomplete and does not correlate with the complete response seen on PET scan. This finding suggests that surgical resection will continue to play a vital role in the treatment of patients with advanced disease responding to IM treatment. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:961 / 963
页数:3
相关论文
共 50 条
  • [31] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07): : 472 - 480
  • [32] PET-CT evaluation of gastrointestinal stromal tumors (GIST) treated with imatinib mesylate.
    Biscontini, Giuseppina
    Nonni, Marco
    Cinti, Paolo
    Rossi, Brunella
    Ascoli, Giorgio
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [33] FDG-PET as a surrogate marker for response to Gleevec™ (imatinib mesylate) in patients with advanced gastrointestinal stromal tumors (GIST).
    Van den Abbeele, AD
    Badawi, RD
    Tetrault, RJ
    Cliche, JP
    Manola, J
    Spangler, T
    Janicek, MJ
    Israel, DA
    Heinrich, MC
    Silberman, SS
    Dimitrijevic, S
    Demetri, GD
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 24P - 25P
  • [34] Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate
    Jacopo Giuliani
    Andrea Bonetti
    ChineseJournalofCancerResearch, 2013, 25 (05) : 486 - 487
  • [35] Imatinib mesylate in treatment of advanced gastrointestinal stromal tumours
    Petricevic, B
    Vrbanec, D
    Belev, B
    Plestina, S
    Herceg, D
    Dedic-Plavetic, N
    ANNALS OF ONCOLOGY, 2005, 16 : 313 - 313
  • [36] Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors
    Seshadri, Ramakrishnan A.
    Rajendranath, Rejiv
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 (04) : 267 - 271
  • [37] MUTATIONAL ANALYSIS BEFORE AND AFTER NEOADJUVANT IMATINIB MESYLATE FOR LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOURS
    Lemke, M.
    Ko, Y. H.
    Law, C.
    Haid, V.
    Rowsell, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 490 - 490
  • [38] Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors
    Kaneko, Manabu
    Emoto, Shigenobu
    Murono, Koji
    Sonoda, Hirofumi
    Hiyoshi, Masaya
    Sasaki, Kazuhito
    Shuno, Yasutaka
    Nishikawa, Takeshi
    Tanaka, Toshiaki
    Hata, Keisuke
    Kawai, Kazushige
    Nozawa, Hiroaki
    SURGERY TODAY, 2019, 49 (06) : 460 - 466
  • [39] Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors
    Manabu Kaneko
    Shigenobu Emoto
    Koji Murono
    Hirofumi Sonoda
    Masaya Hiyoshi
    Kazuhito Sasaki
    Yasutaka Shuno
    Takeshi Nishikawa
    Toshiaki Tanaka
    Keisuke Hata
    Kazushige Kawai
    Hiroaki Nozawa
    Surgery Today, 2019, 49 : 460 - 466
  • [40] Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate
    Giuliani, Jacopo
    Bonetti, Andrea
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (05) : 486 - 487